Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

House Calls and Decision Support: Improving Access to Live Donor Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01786525
Recruitment Status : Active, not recruiting
First Posted : February 8, 2013
Last Update Posted : September 17, 2019
Sponsor:
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by (Responsible Party):
James Rodrigue, Beth Israel Deaconess Medical Center

Brief Summary:
The main purpose of this research program is to reduce the burden of end-stage organ disease on individuals, families, healthcare systems, and society by increasing the availability of donor organs for transplantation. Consistent with this aim, the project further examines strategies to increase access to and reduce disparities - racial, economic, gender - in live donor kidney transplantation (LDKT). Specifically, we expand the research and intensity of an innovative House Calls intervention developed by the principal investigator by including other minorities and socioeconomically disadvantaged patients and by adding a novel Patient-Centered Decision Support component. The main study hypothesis is that participants receiving the novel intervention (House Calls + Patient-Centered Decision Support) will have a higher proportion of LDKT's by the 2-year study endpoint.

Condition or disease Intervention/treatment Phase
Chronic Kidney Disease End-Stage Renal Disease Behavioral: House Calls Behavioral: Web-Based Patient-Centered Decision Support Intervention Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 109 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Health Services Research
Official Title: House Calls and Web-based Decision Support: Improving Access to Live Donor Kidney Transplantation
Study Start Date : June 2013
Actual Primary Completion Date : May 31, 2019
Estimated Study Completion Date : May 31, 2020

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: House Calls only
60-minute educational intervention in patient's home which will be delivered by a health educator.
Behavioral: House Calls
60-minute home based educational intervention which will be administered by a health educator

Active Comparator: House Calls + Web-Based Decision Support
Home based intervention plus web-based patient-centered decision support program that will be offered to participants following the home based intervention.
Behavioral: House Calls
60-minute home based educational intervention which will be administered by a health educator

Behavioral: Web-Based Patient-Centered Decision Support Intervention
Patients will be provided with access to the study website which will allow them to learn and receive LDKT support in a way the best meets their personal values and preferences

No Intervention: Control
100 patients on the Organ Transplant Tracking Record who are not receiving the study intervention



Primary Outcome Measures :
  1. The primary outcome for this study is the proportion of enrolled patients with live donor kidney transplants [ Time Frame: 2 years ]

Secondary Outcome Measures :
  1. Higher proportion of enrolled patients with live donor inquires and evaluations; higher proportion of patients will be in LDKT Readiness stages 4/5 by the 12-week assessment. [ Time Frame: 2 years ]

Other Outcome Measures:
  1. Improvement in LDKT knowledge and LKDT readiness, reduced LDKT concerns and health care mistrust, greater amount of time spent discussing LDKT and higher quality interactions, and improvement in self-efficacy discussing LDKT. [ Time Frame: 12 weeks ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   21 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • non-White race/Hispanic ethnicity/low-income (250% below federal poverty guidelines)
  • CKD/ESRD
  • meets eligibility criteria for kidney transplant waiting list
  • 21 years old or older
  • self-reports being in LDKT Readiness Stage I, II, or III
  • Resides within 3 hours driving time from transplant center

Exclusion Criteria:

  • Awaiting combined kidney-liver transplant
  • Awaiting simultaneous pancreas-kidney transplant
  • Know or suspected cognitive impairment
  • Prior participation in House Calls intervention study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01786525


Locations
Layout table for location information
United States, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
Sponsors and Collaborators
Beth Israel Deaconess Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Investigators
Layout table for investigator information
Principal Investigator: James R Rodrigue, PhD Beth Israel Deaconess Medical Center
Study Chair: Didier Mandelbrot, MD Beth Israel Deaconess Medical Center
Study Chair: Martha Pavlakis, MS Beth Israel Deaconess Medical Center

Layout table for additonal information
Responsible Party: James Rodrigue, Associate Professor, Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier: NCT01786525    
Other Study ID Numbers: 2012P000332
R01DK098727 ( U.S. NIH Grant/Contract )
First Posted: February 8, 2013    Key Record Dates
Last Update Posted: September 17, 2019
Last Verified: September 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by James Rodrigue, Beth Israel Deaconess Medical Center:
Live Donor Kidney Transplantation
LDKT
African American
Disparity
Education
Patient Support
Additional relevant MeSH terms:
Layout table for MeSH terms
Kidney Diseases
Renal Insufficiency, Chronic
Kidney Failure, Chronic
Urologic Diseases
Renal Insufficiency